Redmile Group Fortifies Position In Array Biopharma Inc (ARRY); Broadwood Capital Boosts Stake In STAAR Surgical Company (STAA)

Formerly a portfolio manager at both Whitehall Asset Management and Campbell Advisors, Neal Bradsher founded Broadwood Capital in 2002 and focuses on healthcare and consumer staples stocks. According to its latest 13F filing, Broadwood’s public equity portfolio has an estimated market value of $587 million and comprises six stocks. Bradsher’s top stock pick continues to be Monster Beverage Corporation (NASDAQ:MNST), with his fund holding 1.59 million shares worth some $214 million. He is also betting big on Mallinckrodt PLC (NYSE:MNK), holding 1.62 million shares valued at $190 million.

So far this year, STAAR Surgical Company (NASDAQ:STAA)’s stock has been wobbling around without a clear sense of direction and is currently down by 19% since the beginning of the year. For the three months ending July 3, the company posted revenues of $18.6 million, down 7% year-over-year, and a loss of $0.04 per share. Market analysts eye revenues of $17.8 million and a narrower loss of $0.02 per share for the current quarter. On August 6, STAAR Surgical Company (NASDAQ:STAA) announced the appointment of Dr. Keith Holliday to the position of Vice President, Research and Development, as it bids to extend its operations to other areas of opportunity. Among the hedge funds that we track, the company has attracted the attention of a number of hedge fund managers, notably William Leland Edwards and Philip Hempleman. Edwards’ fund, Palo Alto Investors, reported ownership of 2.64 million shares valued at $25.5 million in its latest 13F filing, while Hempleman’s Ardsley Partners currently holds 608,612 shares, up by 36% during the second quarter.

Disclosure: None